Search

Your search keyword '"David J. Dowling"' showing total 72 results

Search Constraints

Start Over You searched for: Author "David J. Dowling" Remove constraint Author: "David J. Dowling"
72 results on '"David J. Dowling"'

Search Results

1. Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assay

2. Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro

3. Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen

4. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

5. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

6. A protocol for high-throughput screening for immunomodulatory compounds using human primary cells

7. mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

8. Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations

9. Neonatal monocytes demonstrate impaired homeostatic extravasation into a microphysiological human vascular model

10. Precision Vaccine Development: Cues From Natural Immunity

11. Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

12. Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference

13. BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny

14. The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice

15. Adjuvant Effect of Bacille Calmette–Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn

16. Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization

17. A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation From Immunogenicity

18. Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making

19. Precision Vaccine Adjuvants for Older Adults: A Scoping Review

20. Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance

21. Adjuvant Discovery via a High Throughput Screen using Human Primary Mononuclear Cells

22. Shaping neonatal immunization by tuning delivery of synergistic adjuvants via nanocarriers

23. The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems

24. A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations

25. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

26. Shaping Neonatal Immunization by Tuning the Delivery of Synergistic Adjuvants via Nanocarriers

27. An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice

28. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro

29. Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity

30. Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference

31. Toward precision adjuvants: optimizing science and safety

32. Neonatal monocytes demonstrate impaired homeostatic extravasation into a microphysiological human vascular model

33. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity

34. The Sigma class glutathione transferase from the liver fluke Fasciola hepatica.

35. Pentoxifylline inhibits TLR- and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns

36. The TLR5 agonist flagellin modifies phenotypical and enhances functional activation of lung mucosal antigen presenting cells in neonatal mice

37. An adjuvant strategy enabled by modulation of the physical properties of fungal mannans elicits pan-coronavirus reactive anti-SARS-CoV-2 Spike antibodies

38. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization

39. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant

40. Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures*

41. Precision immunology for discovery and development of the Precision Vaccines Program (PVP)-037 small molecule series: imidazopyrimidine adjuvants identified via age-specific human in vitro modeling

42. Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro

43. Pediatric Vaccine Adjuvants

44. Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn

45. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth

46. The effect of stable macromolecular complexes of ionic polyphosphazene on HIV Gag antigen and on activation of human dendritic cells and presentation to T-cells

47. Ontogeny of early life immunity

48. The effects of Fasciola hepatica tegumental antigens on mast cell function

49. Identification of the major proteins of an immune modulating fraction from adult Fasciola hepatica released by Nonidet P40

Catalog

Books, media, physical & digital resources